/CELZ
CELZ Stock - Creative Medical Technology Holdings, Inc.
Healthcare|BiotechnologyNASDAQ
$2.11-4.95%
$0.11 (-4.95%) • Dec 19
38
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.13
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.0
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $2.32
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for CELZ
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$2.09 – $2.13
TARGET (TP)$2.43
STOP LOSS$1.94
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta5.86
52W High$6.90
52W Low$1.69
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $11,000 | $9,000 | $88,600 | $87,754 | $164,500 |
| Gross Profit | $6,600 | $5,400 | $60,109 | $39,805 | $113,904 |
| Gross Margin | 60.0% | 60.0% | 67.8% | 45.4% | 69.2% |
| Operating Income | $-5,743,861 | $-5,620,132 | $-10,244,372 | $-3,125,949 | $-1,114,835 |
| Net Income | $-5,493,481 | $-5,286,574 | $-10,144,044 | $19.21M | $-36,325,230 |
| Net Margin | -49940.7% | -58739.7% | -11449.3% | 21892.8% | -22082.2% |
| EPS | $-3.71 | $-3.76 | $-9.28 | $73.75 | $-626.88 |
Company Overview
Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; StemSpine to treat chronic lower back pain; ImmCelz for the treatment of stroke patients; and OvaStem for treatment of female infertility. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
CELZBeat Rate
44%
Last 16 quarters
Avg Surprise
-111.7%
EPS vs Estimate
Beats / Misses
7/8
1 met exactly
Latest EPS
$-0.48
Q4 2025
EPS Surprise History
Q1 24
-7.1%
$-1.21vs$-1.13
Q2 24
+36.5%
$-0.73vs$-1.15
Q3 24
-32.1%
$-1.11vs$-0.84
Q4 24
+11.8%
$-0.75vs$-0.85
Q1 25
-77.8%
$-1.12vs$-0.63
Q2 25
-59.6%
$-0.83vs$-0.52
Q3 25
+23.8%
$-0.48vs$-0.63
Q4 25
0.0%
$-0.48vs$-0.48
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 7, 2026 | — | — | — | — |
Q1 2026 | Mar 13, 2026 | $-0.37 | — | — | — |
Q4 2025 | Nov 7, 2025 | $-0.48 | $-0.48 | 0.0% | = MET |
Q3 2025 | Aug 8, 2025 | $-0.63 | $-0.48 | +23.8% | ✓ BEAT |
Q2 2025 | May 9, 2025 | $-0.52 | $-0.83 | -59.6% | ✗ MISS |
Q1 2025 | Mar 14, 2025 | $-0.63 | $-1.12 | -77.8% | ✗ MISS |
Q4 2024 | Nov 8, 2024 | $-0.85 | $-0.75 | +11.8% | ✓ BEAT |
Q3 2024 | Aug 9, 2024 | $-0.84 | $-1.11 | -32.1% | ✗ MISS |
Q2 2024 | May 10, 2024 | $-1.15 | $-0.73 | +36.5% | ✓ BEAT |
Q1 2024 | Mar 22, 2024 | $-1.13 | $-1.21 | -7.1% | ✗ MISS |
Q4 2023 | Nov 14, 2023 | $-0.86 | $-1.02 | -18.6% | ✗ MISS |
Q3 2023 | Aug 11, 2023 | $-0.83 | $-0.78 | +6.0% | ✓ BEAT |
Q2 2023 | May 12, 2023 | $-1.00 | $-0.70 | +30.0% | ✓ BEAT |
Q1 2023 | Mar 31, 2023 | $-0.70 | $-0.53 | +24.3% | ✓ BEAT |
Q4 2022 | Nov 10, 2022 | $-0.13 | $-0.07 | +46.2% | ✓ BEAT |
Q3 2022 | Aug 12, 2022 | $-0.15 | $-0.20 | -33.3% | ✗ MISS |
Q2 2022 | May 13, 2022 | $-0.14 | $-0.18 | -28.6% | ✗ MISS |
Q1 2022 | Mar 30, 2022 | $-0.23 | $-4.16 | -1708.7% | ✗ MISS |
Q4 2021 | Dec 6, 2021 | — | $-7.52 | — | — |
Q3 2021 | Aug 16, 2021 | — | $-12.52 | — | — |
Latest News
Creative Medical Technology Completes Patient Enrollment In FDA-Cleared ADAPT Clinical Trial For CELZ-201
📈 PositiveBenzinga•Dec 17, 2025, 02:16 PM
Creative Medical Technology Holdings Says WHO Assigns "Olastrocel" As International Non-Proprietary Name For Lead Cell Therapy CELZ-201
📈 PositiveBenzinga•Dec 2, 2025, 02:19 PM
Creative Medical Technology Launches National BioDefense Inc. Veterans Initiative To Combat Burn Pit Exposure Using AI And Regenerative Cell Therapy
📈 PositiveBenzinga•Oct 30, 2025, 01:18 PM
Creative Medical Advances Two Pivotal FDA-Cleared Clinical Program, ADAPT Trial And CREATE-1 Trial, Targeting Multi-Billion-Dollar Markets
📈 PositiveBenzinga•Oct 27, 2025, 12:31 PM
Creative Medical Pursues New Areas Of Clinical Research Leveraging Proprietary Cellular Platforms, AlloStem, ImmCelz, And iPScelz
📈 PositiveBenzinga•Oct 27, 2025, 12:29 PM
Creative Medical Technologies will be issued US patent number 12,391,925 tomorrow titled "PREVENTION AND/OR TREATMENT OF TYPE 1 DIABETES BY AUGMENTATION OF MYELOID SUPPRESSOR CELL ACTIVITY"
📈 PositiveBenzinga•Aug 18, 2025, 08:02 PM
Frequently Asked Questions about CELZ
What is CELZ's current stock price?
Creative Medical Technology Holdings, Inc. (CELZ) is currently trading at $2.11 per share. The stock has moved -4.95% today.
What is the analyst price target for CELZ?
No analyst price targets are currently available for this stock.
What sector is Creative Medical Technology Holdings, Inc. in?
Creative Medical Technology Holdings, Inc. operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the NASDAQ exchange.
What is CELZ's market cap?
Creative Medical Technology Holdings, Inc. has a market capitalization of $0.01 billion, making it a small-cap company.
Does CELZ pay dividends?
No, Creative Medical Technology Holdings, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorACXP
Acurx Pharmaceuticals, Inc.
$3.33
Mkt Cap: $0.0B
ADIL
Adial Pharmaceuticals, Inc.
$0.24
Mkt Cap: $0.0B
ADXN
Addex Therapeutics Ltd
$7.83
Mkt Cap: $0.0B
ALZN
Alzamend Neuro, Inc.
$2.11
Mkt Cap: $0.0B
APRE
Aprea Therapeutics, Inc.
$0.93
Mkt Cap: $0.0B
BCDA
BioCardia, Inc.
$1.27
Mkt Cap: $0.0B
CDIO
Cardio Diagnostics Holdings, Inc.
$3.23
Mkt Cap: $0.0B
HCWB
HCW Biologics Inc.
$1.57
Mkt Cap: $0.0B
KPRX
Kiora Pharmaceuticals, Inc.
$2.16
Mkt Cap: $0.0B
PHIO
Phio Pharmaceuticals Corp.
$1.07
Mkt Cap: $0.0B
Explore stocks similar to CELZ for comparison